FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:1608-1614 November 30, 2000 Number 22 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Multivitamin supplementation in pregnant women may reduce the risks of cardiovascular defects, oral clefts, and urinary tract defects in their infants. We evaluated whether the folic acid component of multivitamins is responsible for the reduction in risk by examining the associations between maternal use of folic acid antagonists and these congenital malformations.

Methods We assessed exposure to folic acid antagonists that act as dihydrofolate reductase inhibitors and to certain antiepileptic drugs in 3870 infants with cardiovascular defects, 1962 infants with oral clefts, and 1100 infants with urinary tract defects and also in 8387 control infants with malformations the risk of which is not reduced after vitamin supplementation. Mothers were interviewed within six months after delivery about their medication use during pregnancy.

Results The relative risks of cardiovascular defects and oral clefts in infants whose mothers were exposed to dihydrofolate reductase inhibitors during the second or third month after the last menstrual period, as compared with infants whose mothers had no such exposure, were 3.4 (95 percent confidence interval, 1.8 to 6.4) and 2.6 (95 percent confidence interval, 1.1 to 6.1), respectively. The relative risks of cardiovascular defects, oral clefts, and urinary tract defects after maternal exposure to antiepileptic drugs were 2.2 (95 percent confidence interval, 1.4 to 3.5), 2.5 (95 percent confidence interval, 1.5 to 4.2), and 2.5 (95 percent confidence interval, 1.2 to 5.0), respectively. Use of multivitamin supplements containing folic acid diminished the adverse effects of dihydrofolate reductase inhibitors, but not that of antiepileptic drugs.

Conclusions Folic acid antagonists, which include such common drugs as trimethoprim, triamterene, carbamazepine, phenytoin, phenobarbital, and primidone, may increase the risk not only of neural-tube defects, but also of cardiovascular defects, oral clefts, and urinary tract defects. The folic acid component of multivitamins may reduce the risks of these defects.

Source Information

From the Slone Epidemiology Unit, Boston University School of Public Health, Brookline, Mass. (S.H.-D., M.M.W., A.A.M.); and the Department of Epidemiology, Harvard School of Public Health, Boston (S.H.-D., A.M.W.).

Address reprint requests to Dr. Hernández-Díaz at the Slone Epidemiology Unit, Boston University School of Public Health, 1371 Beacon St., Brookline, MA 02446, or at shernan{at}bu.edu.

Full Text of this Article

This article has been cited by other articles:

• Gardiner, H. M, Fouron, J.-C. (2009). Folic acid fortification and congenital heart disease. BMJ 338: b1144-b1144 [Full Text]  
• Ionescu-Ittu, R., Marelli, A. J, Mackie, A. S, Pilote, L. (2009). Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ 338: b1673-b1673 [Abstract] [Full Text]  
• Morrow, J I, Hunt, S J, Russell, A J, Smithson, W H, Parsons, L, Robertson, I, Waddell, R, Irwin, B, Morrison, P J, Craig, J J (2009). Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J. Neurol. Neurosurg. Psychiatry 80: 506-511 [Abstract] [Full Text]  
• Sun, S., Gui, Y., Wang, Y., Qian, L., Liu, X., Jiang, Q., Song, H. (2009). Effects of methotrexate on the developments of heart and vessel in zebrafish. Acta Biochim Biophys Sin 41: 86-96 [Abstract] [Full Text]  
• Wen, S. W. MB PhD, Zhou, J. MB MSc, Yang, Q. MD PhD, Fraser, W. MD MSc, Olatunbosun, O. MD, Walker, M. MSc MD (2008). Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes. CMAJ 179: 1263-1268 [Abstract] [Full Text]  
• Johnson, C. Y, Little, J. (2008). Folate intake, markers of folate status and oral clefts: is the evidence converging?. Int J Epidemiol 37: 1041-1058 [Abstract] [Full Text]  
• Dolk, H., Jentink, J., Loane, M., Morris, J., de Jong-van den Berg, L.T.W., On behalf of The EUROCAT Antiepileptic Drug Workin, (2008). Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?. Neurology 71: 714-722 [Abstract] [Full Text]  
• Brar, H., Einarson, A. (2008). Effects and treatment of inflammatory bowel disease during pregnancy. cfp 54: 981-983 [Abstract] [Full Text]  
• Malik, S., Cleves, M. A., Honein, M. A., Romitti, P. A., Botto, L. D., Yang, S., Hobbs, C. A., and the National Birth Defects Prevention Study, (2008). Maternal Smoking and Congenital Heart Defects. Pediatrics 121: e810-e816 [Abstract] [Full Text]  
• van Beynum, I.M., den Heijer, M., Blom, H.J., Kapusta, L. (2007). The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QJM 100: 743-753 [Abstract] [Full Text]  
• Romitti, P. A., Sun, L., Honein, M. A., Reefhuis, J., Correa, A., Rasmussen, S. A., the National Birth Defects Prevention Study, (2007). Maternal Periconceptional Alcohol Consumption and Risk of Orofacial Clefts. Am J Epidemiol 166: 775-785 [Abstract] [Full Text]  
• Jenkins, K. J., Correa, A., Feinstein, J. A., Botto, L., Britt, A. E., Daniels, S. R., Elixson, M., Warnes, C. A., Webb, C. L. (2007). Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation 115: 2995-3014 [Abstract] [Full Text]  
• COTTRELL, G., MARY, J.-Y., BARRO, D., COT, M. (2007). THE IMPORTANCE OF THE PERIOD OF MALARIAL INFECTION DURING PREGNANCY ON BIRTH WEIGHT IN TROPICAL AFRICA. Am J Trop Med Hyg 76: 849-854 [Abstract] [Full Text]  
• Wilcox, A. J, Lie, R. T., Solvoll, K., Taylor, J., McConnaughey, D R., Abyholm, F., Vindenes, H., Vollset, S. E., Drevon, C. A (2007). Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ 334: 464-464 [Abstract] [Full Text]  
• Artama, M., Isojarvi, J.I.T., Auvinen, A. (2006). Antiepileptic drug use and birth rate in patients with epilepsy--a population-based cohort study in Finland. Hum Reprod 21: 2290-2295 [Abstract] [Full Text]  
• Artama, M., Auvinen, A., Raudaskoski, T., Isojarvi, I., Isojarvi, J. (2005). Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 64: 1874-1878 [Abstract] [Full Text]  
• Orjuela, M. A., Titievsky, L., Liu, X., Ramirez-Ortiz, M., Ponce-Castaneda, V., Lecona, E., Molina, E., Beaverson, K., Abramson, D. H., Mueller, N. E. (2005). Fruit and Vegetable Intake during Pregnancy and Risk for Development of Sporadic Retinoblastoma. Cancer Epidemiol. Biomarkers Prev. 14: 1433-1440 [Abstract] [Full Text]  
• Bailey, L. B, Berry, R. J (2005). Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage. Am. J. Clin. Nutr. 81: 1213S-1217S [Abstract] [Full Text]  
• Wyszynski, D. F., Nambisan, M., Surve, T., Alsdorf, R. M., Smith, C. R., Holmes, L. B., for the Antiepileptic Drug Pregnancy Registry, (2005). Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64: 961-965 [Abstract] [Full Text]  
• Kaplan, P. W. (2004). Reproductive health effects and teratogenicity of antiepileptic drugs. Neurology 63: S13-S23 [Abstract] [Full Text]  
• Lin, Y., Dueker, S. R, Follett, J. R, Fadel, J. G, Arjomand, A., Schneider, P. D, Miller, J. W, Green, R., Buchholz, B. A, Vogel, J. S, Phair, R. D, Clifford, A. J (2004). Quantitation of in vivo human folate metabolism. Am. J. Clin. Nutr. 80: 680-691 [Abstract] [Full Text]  
• Ostensen, M (2004). Disease specific problems related to drug therapy in pregnancy. Lupus 13: 746-750 [Abstract]  
• HOLDING, P. A., KITSAO-WEKULO, P. K. (2004). DESCRIBING THE BURDEN OF MALARIA ON CHILD DEVELOPMENT: WHAT SHOULD WE BE MEASURING AND HOW SHOULD WE BE MEASURING IT?. Am J Trop Med Hyg 71: 71-79 [Abstract] [Full Text]  
• Holmes, L. B., Wyszynski, D. F., Lieberman, E. (2004). The AED (Antiepileptic Drug) Pregnancy Registry: A 6-Year Experience. Arch Neurol 61: 673-678 [Abstract] [Full Text]  
• Mone, S. M., Gillman, M. W., Miller, T. L., Herman, E. H., Lipshultz, S. E. (2004). Effects of Environmental Exposures on the Cardiovascular System: Prenatal Period Through Adolescence. Pediatrics 113: 1058-1069 [Abstract] [Full Text]  
• Tatum, W. O. IV, Liporace, J., Benbadis, S. R., Kaplan, P. W. (2004). Updates on the Treatment of Epilepsy in Women. Arch Intern Med 164: 137-145 [Abstract] [Full Text]  
• Rothenberg, S. P., da Costa, M. P., Sequeira, J. M., Cracco, J., Roberts, J. L., Weedon, J., Quadros, E. V. (2004). Autoantibodies against Folate Receptors in Women with a Pregnancy Complicated by a Neural-Tube Defect. NEJM 350: 134-142 [Abstract] [Full Text]  
• Mitchell, A. A. (2003). Systematic Identification of Drugs That Cause Birth Defects -- A New Opportunity. NEJM 349: 2556-2559 [Full Text]  
• Cot, M, Deloron, P (2003). Malaria prevention strategies: Pregnancy-Associated Malaria (PAM). Br Med Bull 67: 137-148 [Abstract] [Full Text]  
• Hernandez-Diaz, S., Hernan, M. A., Meyer, K., Werler, M. M., Mitchell, A. A. (2003). Case-Crossover and Case-Time-Control Designs in Birth Defects Epidemiology. Am J Epidemiol 158: 385-391 [Abstract] [Full Text]  
• Jugessur, A., Wilcox, A. J., Lie, R. T., Murray, J. C., Taylor, J. A., Ulvik, A., Drevon, C. A., Vindenes, H. A., Abyholm, F. E. (2003). Exploring the Effects of Methylenetetrahydrofolate Reductase Gene Variants C677T and A1298C on the Risk of Orofacial Clefts in 261 Norwegian Case-Parent Triads. Am J Epidemiol 157: 1083-1091 [Abstract] [Full Text]  
• Pennell, P. B. (2003). The importance of monotherapy in pregnancy. Neurology 60: S31-38 [Abstract] [Full Text]  
• Liporace, J., D'Abreu, A. (2003). Epilepsy and Women's Health: Family Planning, Bone Health, Menopause, and Menstrual-Related Seizures. Mayo Clin Proc. 78: 497-506 [Abstract]  
• Kaaja, E., Kaaja, R., Hiilesmaa, V. (2003). Major malformations in offspring of women with epilepsy. Neurology 60: 575-579 [Abstract] [Full Text]  
• Alstead, E M, Nelson-Piercy, C (2003). Inflammatory bowel disease in pregnancy. Gut 52: 159-161 [Abstract] [Full Text]  
• Yang, Q., Erickson, J D. (2003). Influence of reporting error on the relation between blood folate concentrations and reported folic acid-containing dietary supplement use among reproductive-aged women in the United States. Am. J. Clin. Nutr. 77: 196-203 [Abstract] [Full Text]  
• Zetterberg, H., Regland, B., Palmer, M., Rymo, L., Zafiropoulos, A., Arvanitis, D.A., Spandidos, D.A., Blennow, K. (2002). The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion. Hum Reprod 17: 3033-3036 [Abstract] [Full Text]  
• Polifka, J. E., Friedman, J.M. (2002). Medical genetics: 1. Clinical teratology in the age of genomics. CMAJ 167: 265-273 [Abstract] [Full Text]  
• Green, N. S. (2002). Folic Acid Supplementation and Prevention of Birth Defects. J. Nutr. 132: 2356S-2360 [Abstract] [Full Text]  
• Dean, J C S, Hailey, H, Moore, S J, Lloyd, D J, Turnpenny, P D, Little, J (2002). Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J. Med. Genet. 39: 251-259 [Abstract] [Full Text]  
• Alstead, E M (2002). Inflammatory bowel disease in pregnancy. Postgrad. Med. J. 78: 23-26 [Abstract] [Full Text]  
• Jungmann, E. M, Mercey, D., DeRuiter, A., Edwards, S., Donoghue, S., Booth, T., Mohan, D., Lyall, H., Taylor, G. P (2001). Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?. Sex. Transm. Infect. 77: 441-443 [Abstract] [Full Text]  
• Holmes, L. B., Harvey, E. A., Coull, B. A., Huntington, K. B., Khoshbin, S., Hayes, A. M., Ryan, L. M. (2001). The Teratogenicity of Anticonvulsant Drugs. NEJM 344: 1132-1138 [Abstract] [Full Text]  
• Amitai, Y., Leventhal, A., Sharfstein, J. M., Brentlinger, P. E., Newman, R. D., Parise, M., Nahlen, B., Hernandez-Diaz, S., Mitchell, A. A. (2001). Folic Acid Antagonists during Pregnancy and Risk of Birth Defects. NEJM 344: 933-935 [Full Text]  
• (2001). Trimethoprim and Birth Defects. JWatch Infect. Diseases 2001: 1-1 [Full Text]  
• (2001). Folic Acid: Not Just for Neural Tube Defects. JWatch Women's Health 2001: 4-4 [Full Text]  
• Zhao, R., Russell, R. G., Wang, Y., Liu, L., Gao, F., Kneitz, B., Edelmann, W., Goldman, I. D. (2001). Rescue of Embryonic Lethality in Reduced Folate Carrier-deficient Mice by Maternal Folic Acid Supplementation Reveals Early Neonatal Failure of Hematopoietic Organs. J. Biol. Chem. 276: 10224-10228 [Abstract] [Full Text]